Dr. Jou, Yuh-Shan 周玉山 博士

Brand

HIGHLIGHTS
重要成果


  • Overexpressed-eIF3I interacted and activated oncogenic Akt1 is a theranostic target in human hepatocellular carcinoma.
    Hepatology., Mar 04, 2013
    Eukaryotic translation initiation factor 3 subunit I (eIF3I) with transforming capability is often overexpressed in human hepatocellular car ......
    MORE 更多
  • HDAC inhibitors augmented cell migration and metastasis through induction of PKCs leading to identification of low toxicity modalities for combination cancer therapy.
    Clin Cancer Res., Jul 18, 2012
    Histone deacetylase inhibitors (HDACi) are actively explored as new-generation epigenetic drugs but have low efficacy in cancer monotherapy. ......
    MORE 更多
  • IGDB.NSCLC: integrated genomic database of non-small cell lung cancer.
    Nucl. Acids Res, Dec 01, 2011
    Lung cancer is the most common cause of cancer-related mortality with more than 1.4 million deaths per year worldwide. To search for signifi ......
    MORE 更多
  • Somatic LMCD1 mutations promoted cell migration and tumor metastasis in hepatocellular carcinoma.
    Oncogene, Sep 26, 2011
    Common genetic alteration in cancer genomes is implicated for embracing an aberrant cancer gene participated in tumor progression. In this s ......
    MORE 更多
  • IGRhCellID: integrated genomic resources of human cell lines for identification.
    Nucleic Acids Research, Nov 04, 2010
    Cell line identification is emerging as an essential method for every cell line user in research community to avoid using misidentified cell ......
    MORE 更多

List of Highlights
文件紀錄

Top